[Form 4] Stepan Co. Insider Trading Activity

Joaquin Delgado, a director of Stepan Co. (SCL), acquired 2,500 shares of common stock on 05/12/2025 at a reported price of $54.262 per share, increasing his beneficial ownership to 16,071 shares.

Rhea-AI Filing Summary

Joaquin Delgado, a director of Stepan Co. (SCL), acquired 2,500 shares of common stock on 05/12/2025 at a reported price of $54.262 per share, increasing his beneficial ownership to 16,071 shares. The Form 4 discloses only a non-derivative purchase and shows no derivative transactions or dispositions.

Insights

Financial Analyst

TL;DR: Small insider purchase; likely immaterial to valuation but signals insider buying.

The reported acquisition of 2,500 common shares at $54.262 increases the director's stake to 16,071 shares. As a standalone non-derivative purchase of modest size, this transaction is unlikely to move market valuation materially but may be interpreted by some investors as a signal of confidence from management. No other securities classes or dispositions are reported.

Corporate Governance Expert

TL;DR: Routine Section 16 disclosure for a director purchase; no governance concerns evident.

The Form 4 documents a straightforward insider buy by a director with no derivative instruments or unusual transaction codes disclosed. The filing was submitted by an attorney-in-fact, which is a common administrative practice. There are no indications of conflicts, option exercises, or related-party dispositions in the report.

Insider Trade Summary

Grant/Award: 2,500 shares

Grant/Award 1 txn

Insider Delgado Joaquin

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,500	$54.262	$136K

Holdings After Transaction: Common Stock — 16,071 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did Joaquin Delgado report on the Form 4 for SCL?

He reported acquiring 2,500 shares of Stepan Co. common stock on 05/12/2025 at a price of $54.262 per share, bringing total ownership to 16,071 shares.

What type of security was involved in the SCL Form 4?

The transaction involved common stock and is recorded as a non-derivative acquisition; no derivative securities are reported.

What is Joaquin Delgado's relationship to Stepan Co. (SCL)?

The Form 4 identifies Joaquin Delgado as a Director of Stepan Co.

Does the Form 4 show any dispositions or derivative transactions for SCL?

No. The filing shows only an acquisition of common stock and does not disclose any dispositions or derivative transactions.

Who signed or submitted the Form 4 for Joaquin Delgado?

The form indicates it was submitted by James A. Hart as attorney-in-fact for Joaquin Delgado.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/12/2025 - 04:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Delgado Joaquin

(Last) (First) (Middle)

1101 SKOKIE BOULEVARD, SUITE 500

(Street)

NORTHBROOK IL 60062

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STEPAN CO [ SCL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/12/2025		A		2,500	A	$54.262	16,071	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ James A. Hart, attorney-in-fact for Joaquin Delgado	08/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.